本页面由Tiger Trade Technology Pte. Ltd.提供服务

Karyopharm Therapeutics Inc.

0.5051
-0.0999-16.51%
盘前:0.5050-0.0001-0.02%04:19 EDT
成交量:89.86万
成交额:48.26万
市值:1,144.71万
市盈率:-0.04
高:0.6047
开:0.5937
低:0.5020
收:0.6050
52周最高:10.99
52周最低:0.5020
股本:2,266.29万
流通股本:1,729.27万
量比:0.78
换手率:5.20%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
净资产收益率:-891.05%
总资产收益率:-47.61%
市净率:-0.03
市盈率(LYR):-0.03

数据加载中...

2020/03/04

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/03/02

重要事件披露

8-K - Current report
2020/02/28

重要事件披露

Current report, item 5.02
2020/02/26

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

重要事件披露

Current report, item 5.02
2020/02/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/09

重要事件披露

Current report, items 8.01 and 9.01
2019/11/18

超过5%披露

Statement of acquisition of beneficial ownership by individuals